how safe are glp 1 Understanding GLP-1 Drugs: Cost, Safety, and Access in Context Should You Stop and Restart

Clinical trials reveal that 10-15% of participants taking GLP-1 medications like Wegovy or Mounjaro qualify as non-responders, losing less than 5% of their body weight

There is a lack of race-based or regional studies on this entity.11 The epidemiology of MC

When combined with metformin, outcomes may improve further in selected patients

Over time, NAD+ levels naturally decline, leading to fatigue, slower metabolism, brain fog, and decreased resilience

Insulin resistance is present in up to 70% of women with PCOS, and weight gain compounds hyperandrogenism and anovulation

Worsening of diabetic retinopathy with rapid improvement in systemic glucose control - a review